6533b85afe1ef96bd12b9887

RESEARCH PRODUCT

The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients

Oscar PinoJuana Gómez-benitoRafael Tabarés-seisdedosScot E. PurdonManuel J. CuestaManuel FrancoVieta EduardGeorgina GuileraBenedicto Crespo-facorroAnabel Martinez-aranMiguel BernardoFrancisco MesaJavier RejasGemma SafontEmilio Rojo

subject

AdultMalemedicine.medical_specialtyBipolar DisorderBipolar I disorderAdolescentNormsSchizoaffective disorderSCIP-SDiseaseNeuropsychological TestsYoung AdultCognitionmental disordersmedicineHumansBipolar I disorderBipolar disorderYoung adultSchizophreniform disorderPsychiatryLanguagePsychiatric Status Rating ScalesPsychiatrybusiness.industryReproducibility of ResultsCognitionMiddle Agedmedicine.diseaseStandardization dataPsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaFemaleCognition DisordersbusinessResearch ArticleClinical psychology

description

Abstract Background The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to administer scale developed for screening cognitive deficits. This study presents the diagnostic-specific standardization data for this scale in a sample of schizophrenia and bipolar I disorder patients. Methods Patients between 18 and 55 years who are in a stable phase of the disease, diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, or bipolar I disorder were enrolled in this study. Results The SCIP-S was administered to 514 patients (57.9% male), divided into two age groups (18–39 and 40–55 years) and two educational level groups (less than and secondary or higher education). The performance of the patients on the SCIP-S is described and the transformed scores for each SCIP-S subtest, as well as the total score on the instrument, are presented as a percentile, z-score, T-scores, and IQ quotient. Conclusions We present the first jointly developed benchmarks for a cognitive screening test exploring functional psychosis (schizophrenia and bipolar disorder), which provide increased information about patient’s cognitive abilities. Having guidelines for interpreting SCIP-S scores represents a step forward in the clinical utility of this instrument and adds valuable information for its use.

https://doi.org/10.1186/1471-244x-13-127